BFRI
Price
$0.94Alerts
Change
+$0.01 (+1.08%)
Updated
Nov 11 closing price
Capitalization
12.3M
One day until earnings call
Intraday BUY SELL Signals
KMDA
Price
$8.13Alerts
Change
+$0.03 (+0.37%)
Updated
Nov 11 closing price
Capitalization
417.25M
125 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BFRI vs KMDA

BFRI vs KMDA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BFRI vs. KMDA commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFRI is a Hold and KMDA is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BFRI with price predictions
Nov 11, 2026

Momentum Indicator for BFRI turns positive, indicating new upward trend

BFRI saw its Momentum Indicator move above the 0 level on October 28, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 83 similar instances where the indicator turned positive. In 73 of the 83 cases, the stock moved higher in the following days. The odds of a move higher are at 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BFRI's RSI Indicator exited the oversold zone, 22 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 73%.

The Moving Average Convergence Divergence (MACD) for BFRI just turned positive on October 26, 2026. Looking at past instances where BFRI's MACD turned positive, the stock continued to rise in 36 of 44 cases over the following month. The odds of a continued upward trend are 82%.

Following a +5.63% 3-day Advance, the price is estimated to grow further. Considering data from situations where BFRI advanced for three days, in 190 of 234 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BFRI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for BFRI entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.065) is normal, around the industry mean (6.379). P/E Ratio (-1.926) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.202). Dividend Yield (0.000) settles around the average of (0.062) among similar stocks. P/S Ratio (0.307) is also within normal values, averaging (183.387).

The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. BFRI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BFRI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for KMDA with price predictions
Nov 11, 2026

KMDA's RSI Indicator recovers from oversold territory

The RSI Oscillator for KMDA moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 17 similar instances when the indicator left oversold territory. In 14 of the 17 cases the stock moved higher. This puts the odds of a move higher at 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 10, 2026. You may want to consider a long position or call options on KMDA as a result. In 64 of 102 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.

The Moving Average Convergence Divergence (MACD) for KMDA just turned positive on November 10, 2026. Looking at past instances where KMDA's MACD turned positive, the stock continued to rise in 36 of 52 cases over the following month. The odds of a continued upward trend are 69%.

KMDA moved above its 50-day moving average on November 10, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +5.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where KMDA advanced for three days, in 172 of 252 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

KMDA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for KMDA crossed bearishly below the 50-day moving average on October 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 65%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where KMDA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.

The Aroon Indicator for KMDA entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.548) is normal, around the industry mean (6.379). P/E Ratio (19.026) is within average values for comparable stocks, (0.548). Projected Growth (PEG Ratio) (0.644) is also within normal values, averaging (2.202). Dividend Yield (0.094) settles around the average of (0.062) among similar stocks. P/S Ratio (2.487) is also within normal values, averaging (183.387).

The Tickeron Seasonality Score of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. KMDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 76 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
KMDA: Fundamental Ratings
KMDA
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
PROFIT vs RISK RATING
1..100
38
SMR RATING
1..100
76
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
33

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BFRIKMDA
RSI
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
63%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
69%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
68%
Advances
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
68%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 10 days ago
62%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
68%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
64%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (BFRI: $0.94 vs. KMDA: $8.13)
Brand notoriety: BFRI and KMDA are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BFRI: 28% vs. KMDA: 103%
Market capitalization -- BFRI: $12.3M vs. KMDA: $417.25M
BFRI [@Pharmaceuticals: Generic] is valued at $12.3M. KMDA’s [@Pharmaceuticals: Generic] market capitalization is $417.25M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BFRI’s FA Score shows that 1 FA rating(s) are green while KMDA’s FA Score has 1 green FA rating(s).

  • BFRI’s FA Score: 1 green, 4 red.
  • KMDA’s FA Score: 1 green, 4 red.
According to our system of comparison, KMDA is a better buy in the long-term than BFRI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BFRI’s TA Score shows that 4 TA indicator(s) are bullish while KMDA’s TA Score has 6 bullish TA indicator(s).

  • BFRI’s TA Score: 4 bullish, 3 bearish.
  • KMDA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, KMDA is a better buy in the short-term than BFRI.

Price Growth

BFRI (@Pharmaceuticals: Generic) experienced а +3.73% price change this week, while KMDA (@Pharmaceuticals: Generic) price change was +9.57% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.13%. For the same industry, the average monthly price growth was -6.49%, and the average quarterly price growth was +10.54%.

Reported Earning Dates

BFRI is expected to report earnings on Nov 13, 2026.

KMDA is expected to report earnings on Mar 17, 2027.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.13% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
Interact to see
Advertisement

BFRI and

Correlation & Price change

A.I.dvisor tells us that BFRI and CTOR have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and CTOR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
+1.02%
CTOR - BFRI
26%
Poorly correlated
-0.71%
ACET - BFRI
25%
Poorly correlated
-0.33%
KMDA - BFRI
24%
Poorly correlated
+0.37%
SBFM - BFRI
23%
Poorly correlated
-3.51%
LNTH - BFRI
23%
Poorly correlated
-0.02%
More

KMDA and

Correlation & Price change

A.I.dvisor tells us that KMDA and SIGA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KMDA and SIGA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KMDA
1D Price
Change %
KMDA100%
+0.37%
SIGA - KMDA
27%
Poorly correlated
+0.32%
VTRS - KMDA
26%
Poorly correlated
+1.01%
AMRX - KMDA
26%
Poorly correlated
+1.54%
BFRI - KMDA
26%
Poorly correlated
+1.02%
OGI - KMDA
25%
Poorly correlated
+0.15%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XP15.390.59
+3.95%
XP
RDNT.X0.0004540.000009
+2.03%
Radiant Capital cryptocurrency
ETON68.400.86
+1.27%
Eton Pharmaceuticals
RPL.X1.341950-0.002360
-0.18%
Rocket Pool cryptocurrency
C98.X0.011275-0.000300
-2.60%
Coin98 cryptocurrency